Back to Results
First PageMeta Content



A phase II study testing the safety and activity of AGS-003 as an immunotherapeutic in subjects with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib A. Amin1, A. Z. Dudek2, T. Logan3, R.
Add to Reading List

Document Date: 2013-12-05 12:55:31


Open Document

File Size: 428,68 KB

Share Result on Facebook